Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tranexamic Acid (500mg) Injection
Therapeutic Category
Gynecology and Fertility
Dosage Form
Injection
Packaging Type
Ampule
Packaging
5*5
Price
₹71.97/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Traxlink 500 Injection is a potent hemostatic agent that contains Tranexamic Acid, an anti-fibrinolytic, designed to reduce excessive bleeding. Tranexamic acid works by inhibiting fibrinolysis, the process that breaks down blood clots, thereby promoting blood clot formation and preventing excessive bleeding. This medication is commonly used in various surgical procedures, trauma cases, or conditions involving abnormal bleeding, such as menorrhagia (heavy menstrual bleeding), dental surgeries, and after major surgeries like orthopedic or cardiac operations. It is also effective in managing bleeding associated with uterine conditions, including post-partum hemorrhage.
This injection is specifically formulated for intravenous administration, ensuring rapid action in controlling bleeding and stabilizing the patient's condition. The effectiveness and safety of Traxlink 500 Injection are supported by its ability to provide quick relief from bleeding while minimizing the risk of complications like blood loss and anemia.
May cause nausea, vomiting, dizziness, headache, or rare allergic reactions.
Used for the treatment and prevention of excessive bleeding in surgeries, trauma, and conditions like menorrhagia and post-operative bleeding.
Not for use in patients with active blood clotting disorders or thromboembolic disease. Use under medical supervision.
Store at room temperature (15°C to 30°C), away from direct sunlight and heat.
Composition : Tranexamic Acid (250mg) + Ethamsylate (250mg)
Composition : Tranexamic Acid (500mg)
Composition : Enoxaparin (40mg) Injection
Composition : Enoxaparin (60mg) Injection
Composition : Labetalol (5mg/1ml)
Composition : Heparin (5000IU) + Benzyl Alcohol (0.95%) Injection
Composition : Brivaracetam (10mg) Injection
Composition : Levetiracetam (100mg) Injection
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Ondansetron (2mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tranexamic Acid 500mg Injection has strong demand in the critical care, gynecology, surgery, emergency medicine, and hospital care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable and specialty care portfolios.
Medical distributors and agencies can benefit from consistent demand for bleeding management under medical supervision. Tranexamic Acid 500mg is an antifibrinolytic agent that helps reduce excessive bleeding by preventing the breakdown of blood clots Commonly prescribed for surgical procedures, trauma-related bleeding, heavy menstrual bleeding, postpartum hemorrhage management, and other conditions associated with excessive blood loss as per clinical guidelines Injectable formulation provides rapid therapeutic action in acute care and emergency situations Frequently used in hospitals, emergency departments, operation theaters, gynecology units, and critical care settings Widely prescribed by surgeons, gynecologists, anesthesiologists, emergency medicine specialists, and physicians This strengthens a comprehensive hospital care and emergency medicine portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tranexamic Acid 500mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, and attractive margins in the injectable specialty care segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.